Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • tinguzman
    Member
    • Aug 2014
    • 13

    #1

    topGO factor with 2 levels

    Hi,

    I'm trying to do GO enrichment analysis using topgo, but i've encountered a problem, read below. what does factor w/ level 1 mean? it says that i should have 2 level factors.

    geneNames contains my universal set of genes with GO annotation, then myInterestingGenes contains list of differentially expressed genes.


    > myInterestingGenes <- as.vector(AvsB$genes)
    > geneList <- factor(as.integer(geneNames %in% myInterestingGenes))
    > names(geneList) <- geneNames
    > names
    function (x) .Primitive("names")
    > str(geneList)
    Factor w/ 1 level "0": 1 1 1 1 1 1 1 1 1 1 ...
    - attr(*, "names")= chr [1:18756] "Genes" "c10020_g1" "c10035_g1" "c10052_g1" ...


    Error in .local(.Object, ...) : allGenes must be a factor with 2 levels


    how do i fix this?


    Thanks
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    "geneList" is just a bunch of 1s, which means that everything is differentially expressed. What topGO and similar programs expect is a sequence of 0s and 1s, which is then two levels (a sequence of 1s being just one level/value). Typically a value of 0 denotes "not differentially expressed" and 1 "differentially expressed", though you'll have to double check the topGO documentation to ensure it's not the other way around.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...